At the 8th Society for Biomolecular Screening meeting, Genevac will present its latest centrifugal evaporation products for bridging the gap between Medicinal Chemistry and High Throughput Synthesis
At the 8th Society for Biomolecular Screening meeting in The Hague, Netherlands (23rd - 26th September 2002) Genevac will present its latest centrifugal evaporation products for bridging the gap between Medicinal Chemistry and High Throughput Synthesis.
On SBS exhibition stand 2080, Genevac will demonstrate and discuss the solvent removal applications soluble by the recently introduced EZ-2 Personal Evaporator system and the Model HT-4X centrifugal evaporator.
The Model HT-4X is Genevac's optimised system for Drug Discovery laboratories.
Key benefits of the new system include improved speed of evaporation, shorter condenser defrost time, more powerful software (including auto-stop when dry and remote control functions) and the flexibility to accommodate a wide range of sample formats.
The HT-4X retains all the popular aspects of the HT-4 series such as SampleGuard and Dri-Pure to protect samples from overheating and bumping and the high-G direct rotor drive.
Incorporating the latest centrifugal evaporation technology in a compact and easy-to-use benchtop model the EZ-2 Series is priced to be affordable by almost any laboratory.
Intuitive controls and large LCD display provide ease of use comparable to a typical rotary evaporator yet the EZ-2 Series can process many more samples per unit time.
Using proprietary smart evaporator software the EZ-2 provides true walk-away automation so simple and sample safe that anyone can use it with confidence.
